Providers, government need to step up effort on painkiller abuse
The Kaiser survey also examined Americans’ views on issues involving access to mental health services.
FDA drafts guidance for generic drugmakers to create deterrents for painkiller abuse
Modifications from generic drugmakers could, say, make these drugs harder to crush and snort, smoke or dissolve to inject intravenously, as seen in a new FDA draft guidance.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.